In contrast, anti-CD73 Abs significantly downregulated the expression of PD-1 and CTLA-4 by CD4+ and CD8+ T cells in a murine transgenic head and neck squamous cell carcinoma (HNSCC) model, resulting in substantial reduction of tumor growth (95). This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.